Available Technologies   //   Inventor Portal

Get Started with the Polsky Center

Featured

Small Business Spotlight: Qui Solutions Unlocks the Potential Behind BIPOC and Woman-owned Businesses

Read More
See All Podcasts
Small Business Spotlight: Qui Solutions Unlocks the Potential Behind BIPOC and Woman-owned Businesses
1 / 1
Small Business Spotlight: Qui Solutions Unlocks the Potential Behind BIPOC and Woman-owned Businesses

Onchilles Pharma Advancing Tumor-Killing Drug Candidate to the Clinic

University of Chicago spinout Onchilles Pharma plans to initiate first-in-human clinical trials next year for its lead drug candidate – which has demonstrated broad, potent, and direct tumor-killing activity. The…

AbbVie Joins UChicago to Talk Oncology Research, Ongoing Collaboration, and Opportunities for Expansion

The annual UChicago-AbbVie Research Symposium in August celebrated another successful year of the strategic partnership – bringing together academia and industry to exchange new ideas and drive innovation. The event…

Demonstrating Commercial Promise, UChicago Researcher Recognized for Novel Cancer Drug Delivery System

University of Chicago researcher and startup founder Xiaoyang Wu has received the 2022 Duckworth Family Commercial Promise Award for his work developing a novel cancer drug delivery system. The award…

AbbVie, University of Chicago Symposium to Showcase Latest Oncology Research Efforts

The UChicago-AbbVie Research Symposium celebrates another successful year of strategic partnership, showcasing select innovative research efforts in oncology. Taking place Friday, August 19, 2022, the symposium aims to stimulate…

3 Novel Disease-Fighting Technologies You Should Know About Ahead of BIO 2022

Researchers at the University of Chicago have developed methods to increase the clinical efficacy of immunotherapies, provide long-lasting immune tolerance for autoimmune or transplantation therapy, and treat breast and ovarian…

CRISPR-Modified Skin Grafts to Treat Addiction? ‘The Opportunities Are Endless,’ Says CEO

AddGraft Therapeutics has developed a novel platform that aims to effectively treat substance use disorders with genetically engineered skin grafts – a first-of-its-kind treatment with myriad applications. Developed by University…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept